Table 4 Comparison of characteristics according to admission route.
From: Fluid restriction management in the treatment of COVID-19: a single-center observational study
Ambulance (N = 12) | Transfer (N = 43) | P value | |
|---|---|---|---|
Age, years | 68 (53–71) | 59 (51–68) | 0.43 |
HFNC, n (%) | 6 (40) | 17 (32.1) | 0.56 |
HIT, n (%) | 2 (13.3) | 7 (13.2) | 1 |
Tracheostomy, n (%) | 1 (6.7) | 9 (17) | 0.44 |
Chest drainage, n (%) | 2 (13.3) | 9 (17) | 1 |
Weight loss, kg | 3.4 (0.5–5.8) | 5.6 (4.4–9) | 0.026 |
MV duration, days | 7 (5–11) | 9 (5–14) | 0.68 |
ECMO duration, days | 8 (7–8) | 9 (6–12) | 0.72 |
Total dexamethadone, mg | 74 (50–167) | 66 (40–192) | 0.62 |
Hospital LOS, days | 12 (7–17) | 15 (8–24) | 0.36 |
In-hospital mortality, n (%) | 3 (20) | 12 (22.6) | 1 |
